Robert Dempsey

Robert Dempsey serves as the Interim Chief Executive Officer at Ashvattha Therapeutics, Inc. and holds the position of Chair of the Board of Directors at both Azalea Vision and TearSolutions Inc. Furthermore, Robert Dempsey is the Chair of the Board of Directors at iVeena and co-founded the Holland Foundation for Sight Restoration, where involvement includes serving on the Board of Directors. Previous roles include Board Director at Neurotech Pharmaceuticals, Inc., which focuses on developing therapeutics for chronic eye diseases, and Chief Executive Officer of AsclepiX Therapeutics. Educational qualifications include a Master of Business Administration from Northeastern University and a Bachelor's degree in Healthcare Marketing from the same institution.